Abstract
This Frost & Sullivan research service titled Pricing and Reimbursement Issues
for Generics & Biosimilars Markets in Europe provides a detailed analysis of
various issues affecting pricing and reimbursement decisions of generics in
Europe. The study includes an overview of cost-containment measures such as
reference pricing, parallel trade, generic substitution, patient co-payments
and reimbursement. Certain key issues such as the EU accession, the
Roche/Bolar provision, data exclusivity and marketing authorisation
applications are also discussed.
View Cart
